KLRS
#4137
Kalaris Therapeutics, Inc. - Common Stock
2.2 6 USD
-0.04%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-4.24%
Monatliche Änderung
-33.72%
6 month change
-64.07%
Jahresänderung
-77.91%
Vorheriger Schlusskurs
2.3 6
Open
2.3 7
Tief
2.2 2
Hoch
2.3 7
Financials
2026
Current report, Q3 FY2026
Kalaris Therapeutics, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Kalaris Therapeutics, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Kalaris Therapeutics, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Kalaris Therapeutics, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Kalaris Therapeutics, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Kalaris Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Kalaris Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Kalaris Therapeutics, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Kalaris Therapeutics, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Kalaris Therapeutics, Inc. current report, Q1 FY2026
8-K